News | June 06, 2022
Aurobindo Pharma Q4 PAT drops 28% to Rs 576 Cr
Active pharmaceutical ingredients revenue for the quarter was at Rs 913 crore
Active pharmaceutical ingredients revenue for the quarter was at Rs 913 crore
New Regional Processing Lab will serve Ahmedabad and the state of Gujarat
PAYBACK loyalty will be live in 4500 Apollo Pharmacy outlets across India
This expansion announcement came right after raising series B funding of $27 Mn in a round led by Fundamentum Partnership, earlier this month.
Dupixent would be the first and only medicine specifically indicated to treat prurigo nodularis in the U.S., if approved
Evrysdi has proven efficacy in babies, children and adults with more than 5,000 patients treated to date
Trial will assess safety and antibody responses of NVX-CoV2515 to the Omicron variant of COVID-19
Dr Jitendra Singh said, the Biotech Park would act as a hub for incubation of new ideas
JB, in its new avatar, emerges as the fastest growing pharmaceuticals company in India
The new facility at Dombivli is the fifth ASG Eye Hospital in Maharashtra
Subscribe To Our Newsletter & Stay Updated
